No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

SKYRIZI 600 mg, solution à diluer pour perfusion | Pharmacountry

Products
Finished Dosage Forms
Other/Unclassified Dosage Forms
Other Unclassified Dosage Forms

SKYRIZI 600 mg, solution à diluer pour perfusion

AD

Abbvie Deutschland GmbH & Co. KG

Biotech / Biopharmaceutical Company · Biopharmaceutical ProductsGermany

Basic Information

Category

Subcategory & Sub-subcategory

/

Trade Type

Sell

Product Name

SKYRIZI 600 mg, solution à diluer pour perfusion

Details

Substance

Registered Market

Specifications

Dosage Form: Concentrate for solution
Packaging: 1 bottle(s) in glass of 10 mL

Documents

Drug Marketing Authorization Number

Document No.: 64900681

Issue Date: Nov 21, 2022

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Finished Dosage Forms

Other/Unclassified Dosage Forms

Other Unclassified Dosage Forms

RISANKIZUMAB 600 mg